Literature DB >> 8509094

Systemic Pneumocystis carinii pneumonia prophylaxis with dapsone and pyrimethamine fails to protect against extrapulmonary pneumocystosis.

E M Carlin1, R J Coker, R D Goldin, J R Harris.   

Abstract

Extrapulmonary pneumocystosis is a feature of severe immunosuppression which earlier reports have suggested is limited to patients receiving either no prophylaxis or aerosolised pentamidine. We report a case of disseminated pneumocystosis which developed in an HIV positive homosexual man despite systemic primary Pneumocystis carinii pneumonia prophylaxis.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8509094      PMCID： PMC1195046          DOI： 10.1136/sti.69.2.130

Source DB:  PubMed          Journal:  Genitourin Med        ISSN： 0266-4348


  7 in total

1.  Patient tolerance of nebulized pentamidine or cotrimoxazole as secondary prophylaxis for Pneumocystis carinii pneumonia.

Authors:  D E Smith; D A Hills; B G Gazzard
Journal:  AIDS       Date:  1992-09       Impact factor: 4.177

2.  Failure of low-dose dapsone-pyrimethamine in primary prophylaxis of Pneumocystis carinii pneumonia.

Authors:  A Antinori; R Murri; E Tamburrini; A De Luca; L Ortona
Journal:  Lancet       Date:  1992-09-26       Impact factor: 79.321

Review 3.  AIDS and the lung: update 1992. 1. Pneumocystis carinii pneumonia.

Authors:  R F Miller; D M Mitchell
Journal:  Thorax       Date:  1992-04       Impact factor: 9.139

Review 4.  Extrapulmonary pneumocystosis: the first 50 cases.

Authors:  M C Raviglione
Journal:  Rev Infect Dis       Date:  1990 Nov-Dec

5.  Twice-weekly dapsone-pyrimethamine for preventing PCP and cerebral toxoplasmosis.

Authors:  B Clotet; G Sirera; J Romeu; J M Gimeno; A Jou; M J Condom; J Tor; M Foz
Journal:  AIDS       Date:  1991-05       Impact factor: 4.177

6.  Extrapulmonary pneumocystosis.

Authors:  R J Coker; B S Peters
Journal:  Ann Intern Med       Date:  1991-09-15       Impact factor: 25.391

7.  Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom: the changing face of AIDS.

Authors:  B S Peters; E J Beck; D G Coleman; M J Wadsworth; O McGuinness; J R Harris; A J Pinching
Journal:  BMJ       Date:  1991-01-26
  7 in total
  2 in total

Review 1.  Extrapulmonary pneumocystosis.

Authors:  V L Ng; D M Yajko; W K Hadley
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

Review 2.  Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.

Authors:  Anat Stern; Hefziba Green; Mical Paul; Liat Vidal; Leonard Leibovici
Journal:  Cochrane Database Syst Rev       Date:  2014-10-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.